238 related articles for article (PubMed ID: 16938171)
21. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
22. [Expression of interleukin-17 in hepatitis B related liver fibrosis].
Xu Y; DU WJ; Qin LY; Xing ZZ; Qin XH; Chen SJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):133-5. PubMed ID: 19174010
[TBL] [Abstract][Full Text] [Related]
23. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
Zheng M; Cai W; Weng H; Liu R
Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and pathological study on liver fibrosis in viral hepatitis].
Xin S; Mao Y; Wang L; Li Y; Li L; Yu H; Zhao M; Zhang S; Wang S; Wang X; Chen L; Zhou X; Zhou Y; Zou Z; Tang S; Huangpu Y; Zhang L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):240-3. PubMed ID: 15617338
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
26. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
[TBL] [Abstract][Full Text] [Related]
27. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
Xu GG; Luo CY; Wu SM; Wang CL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
[TBL] [Abstract][Full Text] [Related]
28. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.
Pan WD; Xun RY; Chen YM
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):527-31. PubMed ID: 14607680
[TBL] [Abstract][Full Text] [Related]
29. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis.
Takahashi H; Suzuki M; Ikeda H; Kobayashi M; Sase S; Yotsuyanagi H; Maeyama S; Iino S; Itoh F
Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S7-S13. PubMed ID: 18986379
[TBL] [Abstract][Full Text] [Related]
31. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
Sponseller CA; Bacon BR; Di Bisceglie AM
Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
[TBL] [Abstract][Full Text] [Related]
32. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
[TBL] [Abstract][Full Text] [Related]
33. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
34. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
35. [Indigenous and imported low molecular weight heparin in the treatment of chronic hepatitis B and cirrhosis with hepatitis B virus: a prospective randomized controlled clinical study].
Huang JS; Luo X; Yu JX; Liu W; Chen XW; Xie L; Zhu XY; Chen GY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):408-11. PubMed ID: 17631708
[TBL] [Abstract][Full Text] [Related]
36. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension.
Annet L; Materne R; Danse E; Jamart J; Horsmans Y; Van Beers BE
Radiology; 2003 Nov; 229(2):409-14. PubMed ID: 12970464
[TBL] [Abstract][Full Text] [Related]
37. Diffusion-weighted MR imaging of the liver of hepatitis C patients.
Boulanger Y; Amara M; Lepanto L; Beaudoin G; Nguyen BN; Allaire G; Poliquin M; Nicolet V
NMR Biomed; 2003 May; 16(3):132-6. PubMed ID: 12884356
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of disease activity and liver fibrosis in chronic viral hepatitis by magnetic resonance diffusion-weighted imaging].
Yang Y; Song B; Wu B; Lei XZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):155-9. PubMed ID: 19507592
[TBL] [Abstract][Full Text] [Related]
40. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
